1. Home >
  2. M&A >
  3. Going Private >
  4. United States >
  5. Tennessee >
  6. Sanofi Acquires Kaopectate

M&A Deal Summary

Sanofi Acquires Kaopectate

On December 21, 2009, Sanofi acquired consumer products company Kaopectate for 1.9B USD

Acquisition Highlights
  • This is Sanofi’s 3rd transaction in the Consumer Products sector.
  • This is Sanofi’s 6th largest (disclosed) transaction.
  • This is Sanofi’s 3rd transaction in the United States.
  • This is Sanofi’s 1st transaction in Tennessee.
Investment Fate
  • Kaopectate was divested to a consortium of strategic buyers in 2020.

M&A Deal Summary
Date 2009-12-21
Target Kaopectate
Sector Consumer Products
Buyer(s) Sanofi
Deal Type Going Private
Deal Value 1.9B USD

Target

Kaopectate

Chattanooga, Tennessee, United States
Antihistamine Allegra, a brand of Chattem, on display at a Super One grocery store in Duluth, Minnesota.
Antihistamine Allegra, a brand of Chattem, on display at a Super One grocery store in Duluth, Minnesota.
Chattem, Inc. makes and sells household and personal care products like over-the-counter drugs and cosmetics. Chattem was founded in 1879 and is based in Chattanooga, Tennessee.

Search 206,096 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sanofi

Paris, France
Category Company
Founded 1994
Sector Life Science
Employees86,088
Revenue 46.4B EUR (2023)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 9 of 27
Sector: Consumer Products M&A 3 of 3
Type: Going Private M&A Deals 1 of 2
State: Tennessee M&A 1 of 1
Country: United States M&A 3 of 16
Year: 2009 M&A 8 of 8
Size (of disclosed) 6 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-30 Laboratoire Oenobiol S.A.S.

Paris, France

Laboratoire Oenobiol S.A.S. produces, and supplies nutritional, health and beauty supplements. Oenobiol Solaire a nutritional supplement that protects the skin and favours a better suntan by activating melanin synthesis. Oenobiol supplements are scientifically approved products and are manufactured according to pharmaceutical standards.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-02-03 Medley Global Advisors

New York, New York, United States

Medley Global Advisors is the provider of geopolitical and macroeconomic policy information serving a client base comprised of leading banks, asset managers, and hedge funds.

Buy €500M
Mergr

Product

Company

Legal